Unique ID issued by UMIN | UMIN000028761 |
---|---|
Receipt number | R000031806 |
Scientific Title | The efficacy of a human interleukin 12/23 monoclonal antibody and investigation of expression of IL12/23p40 in Crohn disease anorectal lesion. |
Date of disclosure of the study information | 2017/08/21 |
Last modified on | 2019/02/21 09:52:20 |
The efficacy of a human interleukin 12/23 monoclonal antibody and investigation of expression of IL12/23p40 in Crohn disease anorectal lesion.
The efficacy of a human interleukin 12/23 monoclonal antibody and investigation of expression of IL12/23p40 in Crohn disease anorectal lesion.
The efficacy of a human interleukin 12/23 monoclonal antibody and investigation of expression of IL12/23p40 in Crohn disease anorectal lesion.
The efficacy of a human interleukin 12/23 monoclonal antibody and investigation of expression of IL12/23p40 in Crohn disease anorectal lesion.
Japan |
Crohn's disease
Gastroenterology | Gastrointestinal surgery | Adult |
Child |
Others
NO
The aim of this study is to evaluate the efficacy of a human interleukin 12/23 monoclonal antibody on Crohn's disease anorectal lesion by the change in PDAI before and after treatment and the change in the expression level of cytokines including IL12 / 23p40, and to examine the relationship between efficacy and patient characteristics.
Efficacy
the efficacy of a human interleukin 12/23 monoclonal antibody in Crohn's disease anorectal lesion
A Blood cytokine expression status before and after administration of a human interleukin 12/23 monoclonal antibody
Observational
10 | years-old | <= |
Not applicable |
Male and Female
Patients who introduce a human interleukin 12/23 monoclonal antibody in Crohn's disease anal lesion
Age under 10 yrs.
Patients without consent.
100
1st name | |
Middle name | |
Last name | Hiroki Ikeuchi |
Hyogo College of Medicine
Department of Inflammatory Bowel Disease
1-1 Mukogawacho, Nishinomiya, Hyogo, Japan
0798456371
Ikeuci2s@hyo-med.ac.jp
1st name | |
Middle name | |
Last name | Hiroki Ikeuchi |
Hyogo College of Medicine
Department of Inflammatory Bowel Disease
1-1 Mukogawacho, Nishinomiya, Hyogo, Japan
0798456371
Ikeuci2s@hyo-med.ac.jp
Hyogo College of Medicine
Hyogo College of Medicine
Self funding
NO
2017 | Year | 08 | Month | 21 | Day |
Unpublished
Terminated
2017 | Year | 08 | Month | 12 | Day |
2017 | Year | 08 | Month | 12 | Day |
PDAI is evaluated before administration of a human interleukin 12/23 monoclonal antibody and 6 weeks after administration, and cytokines including IL12 / 23p40 are quantified by ELISA.
2017 | Year | 08 | Month | 21 | Day |
2019 | Year | 02 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031806
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |